Skip to main content
SpringerLink
Log in

Riding the biotech rollercoaster

  • Special Report
  • Published:

From Nature

View current issue Submit your manuscript

The biotech scene, although volatile, will continue to provide jobs. But potential employees should prepare for a bumpy ride, say Paul Smaglik and Adam Smith.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. editor of Naturejobs,

    Paul Smaglik

  2. editor of Nature Reviews Drug Discovery,

    Adam Smith

Authors
  1. Paul Smaglik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smaglik, P., Smith, A. Riding the biotech rollercoaster. Nature 418, 4–5 (2002). https://doi.org/10.1038/nj6893-04a

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nj6893-04a

  • Springer Nature Limited

This article is cited by

Search

Navigation